Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.9918
+0.0107 (1.09%)
Aug 14, 2025, 10:50 AM - Market open
Lucid Diagnostics Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Lucid Diagnostics stock ranges from a low of $2.00 to a high of $7.75. The average analyst price target of $3.94 forecasts a 297.26% increase in the stock price over the next year.
Price Target: $3.94 (+297.26%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Lucid Diagnostics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +202.48% | Aug 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +202.48% | Jul 16, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7.5 → $7.75 | Strong Buy | Maintains | $7.5 → $7.75 | +681.41% | Jun 6, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $2 | Buy | Reiterates | $2 | +101.65% | May 15, 2025 |
| Needham | Needham | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +202.48% | May 14, 2025 |
Financial Forecast
Revenue This Year
6.51M
from 4.35M
Increased by 49.70%
Revenue Next Year
19.40M
from 6.51M
Increased by 198.20%
EPS This Year
-0.78
from -1.05
EPS Next Year
-0.35
from -0.78
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.2M | 38.9M | 57.8M | ||
| Avg | 6.5M | 19.4M | 44.5M | ||
| Low | 4.4M | 9.8M | 21.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 112.6% | 497.1% | 198.1% | ||
| Avg | 49.7% | 198.2% | 129.4% | ||
| Low | 1.5% | 50.6% | 10.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.67 | -0.29 | -0.14 | ||
| Avg | -0.78 | -0.35 | -0.25 | ||
| Low | -0.83 | -0.38 | -0.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.